1096 related articles for article (PubMed ID: 23780460)
1. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
Ziegler AG; Rewers M; Simell O; Simell T; Lempainen J; Steck A; Winkler C; Ilonen J; Veijola R; Knip M; Bonifacio E; Eisenbarth GS
JAMA; 2013 Jun; 309(23):2473-9. PubMed ID: 23780460
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
[TBL] [Abstract][Full Text] [Related]
3. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.
Giannopoulou EZ; Winkler C; Chmiel R; Matzke C; Scholz M; Beyerlein A; Achenbach P; Bonifacio E; Ziegler AG
Diabetologia; 2015 Oct; 58(10):2317-23. PubMed ID: 26138334
[TBL] [Abstract][Full Text] [Related]
4. Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study.
Beyerlein A; Bonifacio E; Vehik K; Hippich M; Winkler C; Frohnert BI; Steck AK; Hagopian WA; Krischer JP; Lernmark Å; Rewers MJ; She JX; Toppari J; Akolkar B; Rich SS; Ziegler AG;
J Med Genet; 2019 Sep; 56(9):602-605. PubMed ID: 30287597
[TBL] [Abstract][Full Text] [Related]
5. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion.
Bonifacio E; Krumsiek J; Winkler C; Theis FJ; Ziegler AG
Acta Diabetol; 2014; 51(3):403-11. PubMed ID: 24249616
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.
Achenbach P; Hummel M; Thümer L; Boerschmann H; Höfelmann D; Ziegler AG
Diabetologia; 2013 Jul; 56(7):1615-22. PubMed ID: 23539116
[TBL] [Abstract][Full Text] [Related]
7. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes.
Ziegler AG; Bonifacio E;
Diabetologia; 2012 Jul; 55(7):1937-43. PubMed ID: 22289814
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).
Steck AK; Vehik K; Bonifacio E; Lernmark A; Ziegler AG; Hagopian WA; She J; Simell O; Akolkar B; Krischer J; Schatz D; Rewers MJ;
Diabetes Care; 2015 May; 38(5):808-13. PubMed ID: 25665818
[TBL] [Abstract][Full Text] [Related]
9. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
[TBL] [Abstract][Full Text] [Related]
10. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
Barker JM; Barriga KJ; Yu L; Miao D; Erlich HA; Norris JM; Eisenbarth GS; Rewers M;
J Clin Endocrinol Metab; 2004 Aug; 89(8):3896-902. PubMed ID: 15292324
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
12. Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study.
Vehik K; Lynch KF; Schatz DA; Akolkar B; Hagopian W; Rewers M; She JX; Simell O; Toppari J; Ziegler AG; Lernmark Å; Bonifacio E; Krischer JP;
Diabetes Care; 2016 Sep; 39(9):1535-42. PubMed ID: 27311490
[TBL] [Abstract][Full Text] [Related]
13. Extended family history of type 1 diabetes in HLA-predisposed children with and without islet autoantibodies.
Kuusela S; Keskinen P; Pokka T; Knip M; Ilonen J; Vähäsalo P; Veijola R
Pediatr Diabetes; 2020 Dec; 21(8):1447-1456. PubMed ID: 32939969
[TBL] [Abstract][Full Text] [Related]
14. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
[TBL] [Abstract][Full Text] [Related]
15. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody-defined risk for Type 1 diabetes mellitus in a general population of schoolchildren: results of the Karlsburg Type 1 Diabetes Risk Study after 18 years.
Till AM; Kenk H; Rjasanowski I; Wassmuth R; Walschus U; Kerner W; Schlosser M
Diabet Med; 2015 Aug; 32(8):1008-16. PubMed ID: 25523979
[TBL] [Abstract][Full Text] [Related]
17. Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood.
Vehik K; Haller MJ; Beam CA; Schatz DA; Wherrett DK; Sosenko JM; Krischer JP;
Diabetes Care; 2011 Feb; 34(2):358-62. PubMed ID: 21270193
[TBL] [Abstract][Full Text] [Related]
18. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
[TBL] [Abstract][Full Text] [Related]
19. Predictors of slow progression to diabetes in children with multiple islet autoantibodies.
Steck AK; Dong F; Waugh K; Frohnert BI; Yu L; Norris JM; Rewers MJ
J Autoimmun; 2016 Aug; 72():113-7. PubMed ID: 27255734
[TBL] [Abstract][Full Text] [Related]
20. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
